Met-GP Tablet ER
Marketer
Bi-Cure Remedies
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Met-GP Tablet ER
GlycoBalance XR is a dual-action formulation designed to manage blood glucose. This medication complements diet and exercise to enhance glycemic control in adult patients with type 2 diabetes. It optimizes insulin effectiveness, thus reducing blood sugar. GlycoBalance XR should be administered precisely as prescribed by your physician, including dosage and duration. Ingestion with food is recommended to minimize gastrointestinal discomfort. Missed doses should be taken promptly, unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Exceeding the prescribed dosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function tests will be conducted prior to commencement of therapy. Limit alcohol consumption as it may heighten the likelihood of adverse events.
Uses of Met-GP Tablet ER
Managing type 2 diabetes
Major Benefits of Met-GP Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Met-GP Extended-Release tablets should be taken with a meal.
Common Side effects of Met-GP Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Met-GP Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Met-GP Tablet ER with a meal.
How Met-GP Tablet ER works:
Met-GP ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications utilize distinct mechanisms to achieve superior blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity within the body.
SAFETY ADVICE
AlcoholUNSAFE
Combining Met-GP Tablet ER and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metformin tablets (Met-GP ER) might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metformin (Met-GP Tablet ER) is likely not suitable for use while breastfeeding. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should use extended-release Met-GP tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in those with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Met-GP Tablet ER cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Met-GP Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Met-GP Tablet ER :
Should you forget to take a Met-GP Extended-Release tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Met-GP Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
3,018 People bought this recently